ArticlePsoriasis (Auckland, N.Z.)2025

Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study.

Jiawen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.